Brain Insulin Resistance in Mood Disorders

NCT03915613 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Bipolar Disorder
Anhedonia
Intranasal Insulin

Interventions

DRUG: Humulin R
DRUG: Diluent

Sponsor

University Health Network, Toronto